| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $179.04M | $178.21M | $136.92M | $110.40M | $83.22M |
| R&D | $118.44M | $119.04M | $87.52M | $65.05M | $44.03M |
| SG&A | $60.60M | $59.17M | $49.40M | $45.35M | $39.19M |
| Operating Income | -$179.04M | -$178.21M | -$136.92M | -$110.40M | -$83.22M |
| Interest Expense | $4.50M | $4.50M | $2.20M | $0.00 | $0.00 |
| Tax Expense | -$2.47M | $1.59M | $780.00K | $408.00K | $199.00K |
| Net Income | -$287.86M | -$155.12M | -$118.46M | -$91.50M | -$71.74M |
| EPS (basic) | -3.0800 | -2.3000 | -2.3200 | -2.1600 | -1.7900 |
| EPS (diluted) | -3.0800 | -2.3000 | -2.3200 | -2.1600 | -1.7900 |
| Shares (diluted) | $93.50M | $67.48M | $51.03M | $42.44M | $40.00M |